Advertisement

Pneumocystis jiroveci Pneumonia

  • Abida K. Haque
  • Patrick A. Adegboyega

Abstract

Pneumocystis pneumonia (PCP) is one of the most common pulmonary infections in persons with impaired cell-mediated immunity, and particularly those infected with human immunodeficiency virus (HIV).1, 2, 3, 4, 5, 6, 7 Pneumocystis was first described in the lungs of guinea pigs, during experiments on American trypanosomiasis by Carlos Chagas8 in 1909 and by Antonio Carinii9 in 1910. Both considered the cysts of Pneumocystis as part of the trypanosome’s life cycle. Shortly afterward the Delanoes10 found identical forms in the lungs of rats that had not been infected with trypanosomes and recognized the organism as a separate species. The name Pneumocystis carinii, was given to this organism as a generic name (Greek:pneumon, “lung”; kystis, “cyst”), honoring Carinii.11

Keywords

Cyst Wall Acquire Immune Deficiency Syndrome Acquire Immunodeficiency Syndrome Pneumocystis Carinii Pneumonia Diffuse Alveolar Damage 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Levine SJ. Pneumocystis carinii. Clin Chest Med 1996;17:665–695.PubMedCrossRefGoogle Scholar
  2. 2.
    Catterall JR, Potasman I, Remington JS. Pneumocystis carinii pneumonia in the patient with AIDS. Chest 1985;88:758–762.PubMedCrossRefGoogle Scholar
  3. 3.
    Centers for Disease Control: Kaposi’s sarcoma and Pneumocystis pneumonia among homosexual men-New York City and California. MMWR 1981;30:305–308.Google Scholar
  4. 4.
    Sepkowitz KA. Opportunistic infections in patients with and patients without acquired immunodeficiency syndrome. Clin Infect Dis 2002;34:1098–1107.PubMedCrossRefGoogle Scholar
  5. 5.
    HIV/ AIDS surveillance report. Vol. 9, no. 3. Atlanta: Centers for Disease Control and Prevention, 2003:1–20.Google Scholar
  6. 6.
    Walzer PD, Perl DP, Krogstad DJ, et al. Pneumocystis carinii pneumonia in the United States. Epidemiologic, diagnostic, and clinical features. Ann Intern Med 1974;80:83–93.PubMedCrossRefGoogle Scholar
  7. 7.
    Kovacs JA, Hiemenz JW, Macher AM, et al. Pneumocystis carinii pneumonia: a comparison between patients with the acquired immunodeficiency syndrome and patients with other immunodeficiencies. Ann Intern Med 1984;100:663–671.PubMedCrossRefGoogle Scholar
  8. 8.
    Chagas C. Nova tripanozomiaze humana: estudo sobre a morfolojia e o evolution do Schizotrypanum cruzi n. gen., n. sp., ajente etilojico de nova entidade morbida do homem. Mem Inst Oswaldo Cruz 1909;1:159–218.CrossRefGoogle Scholar
  9. 9.
    Carinii A. Formas de eschizogonia do Trypanozoma lewisi. Commun Soc Med Sao Paolo 1910;16:204.Google Scholar
  10. 10.
    Delanoe P, Delanoe M. Sur les rapports des kystes de carinii du poumon des rats avec le Trypanosoma Lewisi. C R Acad Sci 1912;155:658–660.Google Scholar
  11. 11.
    Dutz W. Pneumocystis carinii pneumonia. Pathol Annu 1970;5:309–341.PubMedGoogle Scholar
  12. 12.
    Van der Meer G, Brug SL. Infection par Pneumocystis chez l’homme et chez les animaux. Ann Soc Belg Med Trop 1942;22:301–307.Google Scholar
  13. 13.
    Armengol CE. A historical review of Pneumocystis carinii. JAMA 1995;273:750–751.CrossRefGoogle Scholar
  14. 14.
    Mills J. Pneumocystis carinii and Toxoplasma gondii infections in patients with AIDS. Rev Infect Dis 1986;8:1001–1011.PubMedCrossRefGoogle Scholar
  15. 15.
    Stringer JR, Beard CB, Miller RF, Wakefield AE. A new name (Pneumocystis jiroveci) for Pneumocystis from humans. Emerg Infect Dis 2002;8:891–896.PubMedCrossRefGoogle Scholar
  16. 16.
    Edman JC, Kovacs JA, Masur H, et al. Ribosomal RNA sequence shows Pneumocystis carinii to be a member of the fungi. Nature 1988;334:519–522.PubMedCrossRefGoogle Scholar
  17. 17.
    Stringer SL, Hudson K, Blasé MA, et al. Sequence from ribosomal RNA of Pneumocystis carinii compared to those of four fungi suggests an ascomycetous affinity. J Protozool 1989;36:14S–16S.PubMedGoogle Scholar
  18. 18.
    Bedrossian CWM. Rapid cytologic diagnosis of Pneumocystis: a comparison of effective techniques. Semin Diag Pathol 1989;6:245–261.Google Scholar
  19. 19.
    Vavra J, Kucera K. Pneumocystis carinii, its ultrastructure and ultrastructural affinities. J Protozool 1970;17:463–483.PubMedGoogle Scholar
  20. 20.
    Sheldon WH. Experimental pulmonary Pneumocystis carinii infection in rabbits. J Exp Med 1959;110:147–160.PubMedCrossRefGoogle Scholar
  21. 21.
    Copland JW. Canine pneumonia caused by Pneumocystis carinii. Aust Vet J 1974;50:515–518.PubMedCrossRefGoogle Scholar
  22. 22.
    McConnell EE, Basson PA, Pienaar JG. Pneumocystis in domestic goat. Onderstepoort J Vet Res 1971;38:117–124. (Hughes WT. Pneumocystis carinii pneumonitis. Vol. 1. Boca Raton, Fla.: CRC Press; 1987.)PubMedGoogle Scholar
  23. 23.
    Siebold HR, Munnell JF Pneumocystis in a pig. Vet Pathol 1977;14:89.CrossRefGoogle Scholar
  24. 24.
    Settnes OP, Hasselager E. Occurrence of Pneumocystis carinii Delanoe & Delanoe, 1912 in dogs and cats in Denmark. Nord Vet Med 1984;36:179–181.PubMedGoogle Scholar
  25. 25.
    Chandler FW, McClure HM, Campbell WG, Watts JC. Pulmonary pneumocystosis in nonhuman primates. Arch Pathol Lab Med 1976;100:163–167.PubMedGoogle Scholar
  26. 26.
    Long GG, White JD, Stookey JL. Pneumocystis carinii infection in splenectomized owl monkeys. J Am Vet Med Assoc 1975;167:651–654.PubMedGoogle Scholar
  27. 27.
    Gigliotti F, Harmsen AG, Haidaris CG, Haidiris PJ. Pneumocystis carinii is not universally transmissible between mammalian species. Infect Immun 1993;61:2886–2890.PubMedGoogle Scholar
  28. 28.
    Thomas CF J., Limper AH. Medical progress: Pneumocystis pneumonia (review article). N Engl J Med 2004;350:2487–2498.PubMedCrossRefGoogle Scholar
  29. 29.
    Wazir JF, Ansari NA. Pneumocystic carinii infection. Update and review. Arch Pathol Lab Med 2004;128:1023–1027.PubMedGoogle Scholar
  30. 30.
    Hughes WT. Natural mode of acquisition for de novo infection with Pneumocystis carinii. J Infect Dis 1982;145:842–848PubMedCrossRefGoogle Scholar
  31. 31.
    Hughes WT, Bartley DL, Smith BM. A natural source of infection due to Pneumocystis carinii. J Infect Dis 1983;147:595.PubMedCrossRefGoogle Scholar
  32. 32.
    Hendley JO, Weller TH. Activation and transmission in rats of infection with Pneumocystis carinii. Proc Soc Exp Biol Med 1971;137:1401–1404.PubMedGoogle Scholar
  33. 33.
    Walzer PD, Schnelle V, Armstrong D, Rosen PP. The nude mouse: a new experimental model for Pneumocystis carinii infection. Science 1977;197:177–179.PubMedCrossRefGoogle Scholar
  34. 34.
    Levine SJ. Pneumocystis carinii. Pulmonary complications of HIV infection. Clin Chest Medicine 1996;17:665–695.CrossRefGoogle Scholar
  35. 35.
    Bartlett M, Cushion MT, Fishman JA, et al. Revised nomenclature for Pneumocystis carinii. J Eukaryotic Microbiol 1994;41:121S.Google Scholar
  36. 36.
    Gigliotti F, Haidaris PJ, Haidaris CG, et al. Further evidence of host species-specific variation in antigens of Pneumocystis carinii using the polymerase chain reaction. J Infect Dis 1993;168:191–194.PubMedCrossRefGoogle Scholar
  37. 37.
    Smulian AG, Walzer PD. The biology of Pneumocystis carinii. CRC Crit Rev Microbiol 1992;18:191–216.CrossRefGoogle Scholar
  38. 38.
    Hughes WT, ed. Pneumocystis carinii pneumonitis. Vol. 1. Boca Raton, FL: CRC Press; 1987.Google Scholar
  39. 39.
    Totet A, Latouche S, Duwat H, et al. Multilocus genotyping of Pneumocystis carinii in patients developing diverse forms of parasitism: implications for a wide human re-servoir for the fungus. J Eukaryotic Microbiol 2003;50S:670–671.CrossRefGoogle Scholar
  40. 40.
    Totet A, Latouche S, Lacube P, et al. Pneumocystis jeroveci dihydropteroate synthase genotypes in immunocompetent infants and immunosuppressed adults, Amiens, France. Emerg Infect Dis 2004;10:667–673.PubMedCrossRefGoogle Scholar
  41. 41.
    Cushion MT. Transmission and epidemiology. In: Walzer PD, ed. Pneumocystis carinii pneumonia. 2nd ed. New York: Marcel Dekker; 1994:123.Google Scholar
  42. 42.
    Vargas SL, Hughes WT, Santolaya ME, et al. Search for primary infection by Pneumocystis carinii in a cohort of normal, healthy infants. Clin Infect Dis 2001;32:855–861.PubMedCrossRefGoogle Scholar
  43. 43.
    Pifer LL, Hughes WT, Stango S, et al. Pneumocystis carinii infection: evidence for high prevalence in normal and immunosuppressed children. Pediatrics 1978;61:35–41.PubMedGoogle Scholar
  44. 44.
    Lundgren B. Pneumocystis carinii: antigenic, immunological and molecular characterization. Dan Med Bull 1994;41:306–318.PubMedGoogle Scholar
  45. 45.
    Lundgren B, Kovacs JA, Mathiesen L, et al. IgM response to a human Pneumocystis carinii surface antigen in HIV infected patients with pulmonary symptoms. Scand J Infect Dis 1993;25:515–520.PubMedCrossRefGoogle Scholar
  46. 46.
    Leigh TR, Kangro HO, Gazzard BG, et al. DNA amplification by the polymerase chain reaction to detect sub-clinical Pneumocystis carinii colonization in HIV-positive and HIV-negative male homosexuals with and without respiratory symptoms. Respir Med 1993;87:525–529.PubMedCrossRefGoogle Scholar
  47. 47.
    Peters SE, Wakefield AE, Sinclair K, et al. A search for P. carinii in postmortem lungs by DNA amplification. J Pathol 1992;166:195–198.PubMedCrossRefGoogle Scholar
  48. 48.
    Wakefield AE, Pixley FJ, Banerji S, et al. Detection of Pneumocystis carinii with DNA amplification. Lancet 1990;336:451–453.PubMedCrossRefGoogle Scholar
  49. 49.
    Vargas SI, Hughes WT, Wakefield AE, et al. Limited persistence in and subsequent elimination of Pneumocystis carinii from the lungs after P. carinii pneumonia. J Infect Dis 1995;172:506–510.PubMedCrossRefGoogle Scholar
  50. 50.
    Cushion MT, Stringer JR, Walzer PD. Cellular and molecular biology of Pneumocystis carinii. Int Rev Cytol 1991;131:59–107.PubMedCrossRefGoogle Scholar
  51. 51.
    Sepkowitz K, Schluger N, Godwin T, et al. DNA amplification in experimental Pneumocystosis: characterization of serum Pneumocystis carinii DNA and potential P. carinii carrier states. J Infect Dis 1993;168:421–426.PubMedCrossRefGoogle Scholar
  52. 52.
    Chave JP, David S, Wauters JP, et al. Transmission of Pneumocystis carinii from AIDS patients to other immunosuppressed patients: a cluster of Pneumocystis carinii pneumonia in renal transplant patients. AIDS 1991;5:927–932.PubMedCrossRefGoogle Scholar
  53. 53.
    Chusid MJ, Heyrman KA. An outbreak of Pneumocystis carinii pneumonia at a pediatric hospital. Pediatrics 1978;62:1031–1035.PubMedGoogle Scholar
  54. 54.
    Ruebask TK II, Weinstein RA, Baekner RL, et al. An outbreak of Pneumocystis pneumonia in children with acute lymphocytic leukemia. Am J Dis Child 1978;132:143–148.Google Scholar
  55. 55.
    Santiago-Delpin EA, Mora E, Gonzalez ZA, et al. Factors in an outbreak of Pneumocystis carinii in a transplant unit. Transplant Proc 1988;20:462–465.PubMedGoogle Scholar
  56. 56.
    Singer C, Armstrong D, Rosen PP, et al. Pneumocystis carinii pneumonia: a cluster of eleven cases. Ann Intern Med 1975;82:772–777.PubMedCrossRefGoogle Scholar
  57. 57.
    Peglow SL, Smulian GA, Linke MJ, et al. Serologic responses to specific Pneumocystis carinii antigens in health and disease. J Infect Dis 1990;161:296–306.PubMedCrossRefGoogle Scholar
  58. 58.
    Smulian AG, Linke MJ, Baughman RP, et al. Characterization of Pneumocystis carinii antigen in bronchoalveolar lavage fluid by Western blot. Unpublished observations.Google Scholar
  59. 59.
    Ma L, Jia Q, Kovacs JA. Development of a yeast assay for rapid screening of inhibitors of human-derived Pneumocystis carinii dihydrofolate reductase. Antimicrob Agents Chemother 2002;46:3101–3103.PubMedCrossRefGoogle Scholar
  60. 60.
    Kovacs JA, Powell F, Edman JC, et al. Multiple genes encode the major surface glycoprotein of Pneumocystis carinii. J Biol Chem 1993;268:6034–6040.PubMedGoogle Scholar
  61. 61.
    Barton EG Jr, Campbell WG Jr. Further observations on the ultrastructure of Pneumocystis. Arch Pathol 1967;83:527–534.PubMedGoogle Scholar
  62. 62.
    Barton EG Jr, Campbell WG Jr. Pneumocystis carinii in lungs of rats treated with cortisone acetate: ultrastructural observations relating to the life cycle. Am J Pathol 1969;54:209–236.PubMedGoogle Scholar
  63. 63.
    Campbell WG Jr.Ultrastructure of Pneumocystis in human lung: life cycle in human pneumocystosis. Arch Pathol 1972;93:312–324.PubMedGoogle Scholar
  64. 64.
    Gutierrez Y. The biology of Pneumocystis carinii. Semin Diagn Pathol 1989;6:203–211.PubMedGoogle Scholar
  65. 65.
    Bedrossian CWM. Ultrastructure of Pneumocystis carinii: a review of internal and surface characteristics. Semin Diagn Pathol 1989;6:212–237.PubMedGoogle Scholar
  66. 66.
    Matsumoto Y, Yoshida Y. Sporogony in Pneumocystis carinii: synaptonemal complexes and meiotic nuclear divisions observed in precysts. J Protozool 1984;31:420–428.PubMedGoogle Scholar
  67. 67.
    Hasleton PS, Curry A, Rankin EM. Pneumocystis carinii pneumonia: a light microscopical and ultrastructural study. J Clin Pathol 1981;34:1138–1146.PubMedCrossRefGoogle Scholar
  68. 68.
    Cushion MT, Ruffolo JJ, Walzer PD. Analysis of the developmental stages of Pneumocystis carinii, in vitro. Lab Invest 1988;58:324–331.PubMedGoogle Scholar
  69. 69.
    Garrison RG, Arnold WM. Atlas of cell morphology. In: Arnold WN, ed. Yeast cell envelopes: biochemistry, biophysics, and ultrastructure. Vol. 1. Boca Raton, FL: CRC Press, 1981:5.Google Scholar
  70. 70.
    Zierdt CH. Studies of Blastocystis hominis. J Protozool 1973;20:114–121.PubMedGoogle Scholar
  71. 71.
    Yoshikawa H, Yoshida Y. Freeze-fracture studies on Pneumocystis carinii. I. Structural alterations of the pellicle during the development trophozoite to cyst. Z. Parasitenkd 1986;72:463–477.CrossRefGoogle Scholar
  72. 72.
    Yokishawa H, Tegoshi T, Yoshida YY. Detection of surface carbohydrates on Pneumocystis carinii by fluorescein-conjugated lectins. Parasitol Res 1987;74:43–49.CrossRefGoogle Scholar
  73. 73.
    Kaneshiro ES, Cushion MT, Walzer PD, et al. Analyses of Pneumocystis fatty acids. J Protozool 1989;36:69S–72S.PubMedGoogle Scholar
  74. 74.
    Matsumoto Y, Matsuda S, Tegoshi T. Yeast glucan in the cyst wall of Pneumocystis carinii. J Protozool 1989;36:21S–22S.PubMedGoogle Scholar
  75. 75.
    Linke MJ, Cushion MT, Walzer PD. Properties of the major rat and human Pneumocystis carinii antigens. Infect Immun 1989;57:1547–1555.PubMedGoogle Scholar
  76. 76.
    Yoshikawa H, Morioka H, Yoshida Y. Ultrastructural detection of carbohydrates in the pellicle of Pneumocystis carinii. Parasitol Res 1988;74:537–543.PubMedCrossRefGoogle Scholar
  77. 77.
    Dei-Cas E, Soulez B, Camus D. Ultrastructural study of Pneumocystis carinii in explant cultures of rabbit lung and in cultures with and without feeder cells. J Protozool 1989;36:55S–57S.PubMedGoogle Scholar
  78. 78.
    Vossen MEMH, Beckers PJA, Meuwissen JEH Th, et al. Developmental biology of Pneumocystis carinii, an alternative view on the life cycle of the parasite. Z Parasitenkd 1978;55:101–118.PubMedCrossRefGoogle Scholar
  79. 79.
    Watts JC, Chandler FW. Pneumocystis carinii pneumonitis: the nature and diagnostic significance of the methenamine silver-positive “intracystic bodies.” Am J Surg Pathol 1985;9:744–751.PubMedCrossRefGoogle Scholar
  80. 80.
    Mahan CT, Sale GE. Rapid methenamine silver stain for Pneumocystis and fungi. Arch Pathol Lab Med 1978;102:351–352.PubMedGoogle Scholar
  81. 81.
    Pintozzi RL. Modified Grocott’s methenamine silver nitrate method for quick staining of Pneumocystis carinii. J Clin Pathol 1978;31:803–805.PubMedCrossRefGoogle Scholar
  82. 82.
    Musto L, Flanigan MJ, Elbadawi A. Ten-minute silver stain for Pneumocystis carinii and fungi in tissue sections. Arch Pathol Lab Med 1982;106:292–294.PubMedGoogle Scholar
  83. 83.
    Brinn NT. Rapid metallic histological staining using the microwave oven. J Histotechnol 1983;6:125–129.CrossRefGoogle Scholar
  84. 84.
    Shimono LH, Hartman B. A simple and reliable rapid methenamine silver stain for Pneumocystis carinii and fungi. Arch Pathol Lab Med 1986;110:855–856.PubMedGoogle Scholar
  85. 85.
    Lundgren B, Cotton R, Lundgren JD, et al. Identification of Pneumocystis carinii chromosomes and mapping of five genes. Infect Immun 1990;58:1705–1710.PubMedGoogle Scholar
  86. 86.
    Hong ST, Steele PE, Cushion MT, et al. Pneumocystis carinii karyotypes. J Clin Microbiol 1990;28:1785–1795.PubMedGoogle Scholar
  87. 87.
    Stringer SL, Stringer JR, Blasé MA, et al. Pneumocystis carinii: sequence from ribosomal RNA implies a close relationship with fungi. Exp Parasitol 1989;68:450–461.PubMedCrossRefGoogle Scholar
  88. 88.
    Edman U, Edman JC, Lundgren B, et al. Isolation and expression of Pneumocystis carinii thymidylate synthase gene. Proc Natl Acad Sci USA 1989;86:6503–6507.PubMedCrossRefGoogle Scholar
  89. 89.
    Edman JC, Edman U, Cao M, Lundgren B, Kovacs JA, Santi DV. Isolation and expression of the Pneumocystis carinii dihydrofolate reductase gene. Proc Natl Acad Sci USA 1989;86:8625–8629.PubMedCrossRefGoogle Scholar
  90. 90.
    Latouche S, Lacube P, Maury E, et al. Pneumocystis jeroveci dihydropteroate synthase genotypes in French patients with pneumocystosis: a 1998–2001 prospective study. Med Mycology 2003;41:533–537.CrossRefGoogle Scholar
  91. 91.
    Crothers K, Beard CB, Turner J, et al. Severity and outcome of HIV-associated Pneumocystis pneumonia containing Pneumocystis jiroveci dihydropteroate synthase gene mutations. AIDS 2005;19:801–805.PubMedCrossRefGoogle Scholar
  92. 92.
    Kazanjian PH, Fisk D, Armstrong W, et al. Increase in prevalence of Pneumocystis carinii mutations in patients with AIDS and P. carinii pneumonia, in the United States and China. J Infect Dis 2004;189:1684–1687.PubMedCrossRefGoogle Scholar
  93. 93.
    Matos O, Lee CH, Jin S, et al. Pneumocystis jiroveci in Portuguese immunocompromised patients: association of specific ITS genotypes with treatment failure, bad clinical outcome and childhood. Inf Genet Evol 2003;3:281–285.CrossRefGoogle Scholar
  94. 94.
    Graves DC, McNabb SJN, Ivey MH, Worley MA. Development and characterization of monoclonal antibodies to Pneumocystis carinii. Infect Immun 1986;51:125–133.PubMedGoogle Scholar
  95. 95.
    Kovacs JA, Halpern JL, Swan JC, et al. Identification of antigens and antibodies specific for Pneumocystis carinii. J Immunol 1988;140:2023–2031.PubMedGoogle Scholar
  96. 96.
    Walzer PD, Linke MJ. A comparison of the antigenic characteristics of rat and human Pneumocystis carinii by immunoblotting. J Immunol 1987;138:2257–2265.PubMedGoogle Scholar
  97. 97.
    Kovacs JA, Halpern JL, Lundgren B, et al. Monoclonal antibodies to Pneumocystis carinii: identification of specific antigens and characterization of antigenic differences between rat and human isolates. J Infect Dis 1989;159:60–70.PubMedCrossRefGoogle Scholar
  98. 98.
    Meuwissen JHE, Tauber I, Leewenberg ADEM, et al. Parasitologic and serologic observations of infection with Pneumocystis in humans. J Infect Dis 1977;136:43–49.PubMedCrossRefGoogle Scholar
  99. 99.
    Masur H, Jones TC. The interaction in vitro of Pneumocystis carinii with macrophages and L-cells. J Exp Med 1978;147:157–170.PubMedCrossRefGoogle Scholar
  100. 100.
    Phair J, Munoz A, Detels R, et al. The risk of Pneumocystis carinii pneumonia among men infected with human immunodeficiency virus type I. N Engl J Med 1990;322:161–165.PubMedCrossRefGoogle Scholar
  101. 101.
    Afessa B, Green W, Chiao J, et al. Pulmonary complications of HIV infection: autopsy findings. Chest 1998;113:1225–1229.PubMedCrossRefGoogle Scholar
  102. 102.
    Gigliotti F, Stokes DC, Cheatham AB, et al. Development of murine monoclonal antibodies to Pneumocystis carinii. J Infect Dis 1986;154:315–322.PubMedCrossRefGoogle Scholar
  103. 103.
    Vuk-Pavlovic Z, Standing JE, Crouch EC, et al. Carbohydrate recognition domain of surfactant protein D mediates interactions with Pneumocystis carinii glycoprotein A. Am J Resp Cell Mol Biol 2001;24:475–484.CrossRefGoogle Scholar
  104. 104.
    O’Riordan DM, Standing JE, Limper AH. Pneumocystis carinii glycoprotein A binds macrophage mannose receptors. Infect Immun 1995;63:779–784.PubMedGoogle Scholar
  105. 105.
    Kottom TJ, Limper AH. Cell wall assembly by Pneumocystis carinii: evidence for a unique gsc-1 subunit mediating beta-l,3-glucan deposition. J Biol Chem 2000;275:40628–40634.PubMedCrossRefGoogle Scholar
  106. 106.
    Schmatz DM, Romancheck MA, Pittarelli LA., et al. Treatment of Pneumocystis carinii pneumonia with 1,3-beta-glucan synthesis inhibitors. Proc Natl Acad Sci USA 1990;87:5950–5954.PubMedCrossRefGoogle Scholar
  107. 107.
    Powles MA, Liberator P, Anderson J, et al. Efficacy of MK-991 (L-743,872), a semisynthetic pneumocandin, in murine models of Pneumocystis carinii. Antimicrob Agents Chemother 1998;42:1985–1989.PubMedGoogle Scholar
  108. 108.
    Vassallo R, Standing JE, Limper AH. Isolated Pneumocystis carinii cell wall glucan provokes lower respiratory tract inflammatory responses. J Immunol 2000;164:3755–3763.PubMedGoogle Scholar
  109. 109.
    Hahn PY, Evans SE, Kottom TJ, Standing JE, Pagano RE, Limper AH. Pneumocystis carinii cell wall beta-glucan induces release of macrophage inflammatory protein-2 from alveolar epithelial cells via a lactosylceramide-mediated mechanism. J Biol Chem 2003;278:2043–2050.PubMedCrossRefGoogle Scholar
  110. 110.
    Thomas CF, Anders RA, Gustafson MP, et al. Pneumocystis carinii contains a functional cell-division-cycle Cdc2 homologue. Am J Respir Cell Mol Biol 1998;18:297–306.PubMedCrossRefGoogle Scholar
  111. 111.
    Gustafson MP, Thomas CF Jr, Rusnak F, et al. Differential regulation of growth and checkpoint control mediated by a Cdc25 mitotic phosphatase from Pneumocystis carinii. J Biol Chem 2001;276:835–843.PubMedCrossRefGoogle Scholar
  112. 112.
    Kottom TJ, Thomas CF Jr, Mubarak KK, et al. Pneumocystis carinii uses a functional cdc13 B-type cyclin complex during its life cycle. Am J Respir Cell Mol Biol 2000;22:722–731.PubMedCrossRefGoogle Scholar
  113. 113.
    Vohra PK, Puri V, Thomas CF Jr. Complementation and characterization of the Pneumocystis carinii MAPK, PCM. FEBS Lett 2003;551:139–146.PubMedCrossRefGoogle Scholar
  114. 114.
    Kottom TJ, Kohler JR, Thomas CF Jr, et al. Lung epithelial cells and extracellular matrix components induce expression of Pneumocystis carinii STE20, a gene complementing the mating and pseudohyphal growth defects of STE20 mutant yeast. Infect Immun 2003;71:6463–6471.PubMedCrossRefGoogle Scholar
  115. 115.
    Vohra PK, Puri V, Kottom TJ, et al. Pneumocystis carinii STE11, an HMG-box protein, is phosphorylated by the mitogen activated protein kinase PCM. Gene 2003;312:173–179.PubMedCrossRefGoogle Scholar
  116. 116.
    Smulian AG, Sesterhenn T, Tanaka R, et al. The ste3 pheromone receptor gene of Pneumocystis carinii is surrounded by a cluster of signal transduction genes. Genetics 2001;157:991–1002.PubMedGoogle Scholar
  117. 117.
    Morales IJ, Vohra PK, Puri V, et al. Characterization of a lanosterol 14 alpha-demethylase from Pneumocystis carinii. Am J Respir Cell Biol 2003;29:232–238.Google Scholar
  118. 118.
    Kaneshiro ES, Rosenfeld JA, Basselin-Eiweida M, et al. The Pneumocystis carinii drug target S-adenosyl-L-metionine:sterol C-24 methyl transferase has a unique substrate preference. Mol Microbiol 2002;44:989–999.PubMedCrossRefGoogle Scholar
  119. 119.
    Walzer PD. Attachment of microbes to host cells: relevance of Pneumocystis carinii. Lab Invest 1986;54:589–592.PubMedGoogle Scholar
  120. 120.
    Limper AH, Standing JE, Hoffman OA, Castro M, Neese LW. Vitronectin binds to Pneumocystis carinii and mediates organism attachment to cultured lung epithelial cells. Infect Immun 1993;61:4302–4309.PubMedGoogle Scholar
  121. 121.
    Beck JM, Preston AM, Wagner JG, et al. Interaction of rat Pneumocystis carinii and rat alveolar epithelial cells in vitro. Am J Physiol 1998;275:L118–L125.PubMedGoogle Scholar
  122. 122.
    Limper AH, Edens M, Anders RA, et al. Pneumocystis carinii inhibits cyclin-dependent kinase activity in lung epithelial cells. J Clin Invest 1998;101:1148–1155.PubMedCrossRefGoogle Scholar
  123. 123.
    O’Riordan DM, Standing JE, Kwon KY, et al. Surfactant protein D interacts with Pneumocystis carinii and mediates organism adherence to alveolar macrophages. J Clin Invest 1995;95:2699–2710.PubMedCrossRefGoogle Scholar
  124. 124.
    Beers MF, Atochina EN, Preston AM, et al. Inhibition of lung surfactant protein B expression during Pneumocystis carinii pneumonia in mice. J Lab Clin Med 1999;133:423–433.PubMedCrossRefGoogle Scholar
  125. 125.
    Williams MD, Wright JR, March KL, et al. Human surfactant protein A enhances attachment of Pneumocystis carinii to rat alveolar macrophages. Am J Respir Cell Mol Biol 1996;14:232–238.PubMedCrossRefGoogle Scholar
  126. 126.
    Koziel H, Phelps DS, Fishman JA, et al. Surfactant protein-A reduces binding and phagocytosis of Pneumocystis carinii by human alveolar macrophages in vitro. Am J Respir Cell Mol Biol 1998;18:834–843.PubMedCrossRefGoogle Scholar
  127. 127.
    Yong SJ, Vuk-Pavlovic Z, Standing JE, et al. Surfactant protein D-mediated aggregation of Pneumocystis carinii impairs phagocytosis by alveolar macrophages. Infect Immun 2003;71:1662–1671.PubMedCrossRefGoogle Scholar
  128. 128.
    Wright TW, Notter RH, Wang Z, et al. Pulmonary inflammation disrupts surfactant function during Pneumocystis carinii pneumonia. Infect Immun 2001;69:758–764.PubMedCrossRefGoogle Scholar
  129. 129.
    Gigliotti F, Hughes WT. Passive immunoprophylaxis with specific monoclonal antibody confers partial protection against Pneumocystis carinii pneumonitis in animal models. J Clin Invest 1988;81:1666–1668.PubMedCrossRefGoogle Scholar
  130. 130.
    Shellito J, Suzara VV, Blumenfeld W, et al. A new model of Pneumocystis carinii infection in mice selectively depleted of helper T lymphocytes. J Clin Invest 1990;85:1686–1693.PubMedCrossRefGoogle Scholar
  131. 131.
    Beck JM, Harmsen AG. Lymphocytes in host defense against Pneumocystis carinii. Semin Respir Infect 1998;13:330–338.PubMedGoogle Scholar
  132. 132.
    Wright TW, Johnston CJ, Harmsen AG, et al. Chemokine gene expression during Pneumocystis carinii-driven pulmonary inflammation. Infect Immun 1999;67:3452–3460.PubMedGoogle Scholar
  133. 133.
    Beck JM, Liggitt HD, Brunette EN, et al. Reduction in intensity of Pneumocystis carinii pneumonia in mice by aerosol administration of gamma interferon. Infect Immun 1991;59:3859–3862.PubMedGoogle Scholar
  134. 134.
    Downing JF, Kachel DL, Pasula R, et al. Gamma interferon stimulates rat alveolar macrophages to kill Pneumocystis carinii by L-arginine-and tumor necrosis factor-dependent mechanisms. Infect Immun 1999;67:1347–1352.PubMedGoogle Scholar
  135. 135.
    Ezekowitz RA, Williams DJ, Koziel H, et al. Uptake of Pneumocystis carinii mediated by the macrophage mannose receptor. Nature 1991;351:155–158.PubMedCrossRefGoogle Scholar
  136. 136.
    Limper AH, Hoyte JS, Standing JE. The role of macrophages in Pneumocystis carinii degradation and clearance from the lung. J Clin Invest 1997;99:2110–2117.PubMedCrossRefGoogle Scholar
  137. 137.
    Koziel H, Eichbaum Q, Kruskal BA, et al. Reduced binding and phagocytosis of Pneumocystis carinii by alveolar macrophages from persons infected with HIV-1 correlates with mannose receptor down regulation. J Clin Invest 1998;102:1332–1344.PubMedCrossRefGoogle Scholar
  138. 138.
    Vassallo R, Kottom TJ, Standing JE, et al. Vitronectin and fibronectin function as glucan binding proteins augmenting macrophage responses to Pneumocystis carinii. Am J Respir Cell Mol Biol 2001;25:203–211.PubMedCrossRefGoogle Scholar
  139. 139.
    Brown GD, Gordon S. Immune recognition: a new receptor for beta-glucans. Nature 2001;413:36–37.PubMedCrossRefGoogle Scholar
  140. 140.
    Hoffman OA, Standing JE, Limper AH. Pneumocystis carinii stimulates tumor necrosis factor-alpha release from alveolar macrophages through a beta-glucan-mediated mechanism. J Immunol 1993;150:3932–3940.PubMedGoogle Scholar
  141. 141.
    Chen W, Havell EA, Harmsen AG. Importance of endogenous tumor necrosis factor alpha and gamma interferon in host resistance against Pneumocystis carinii infection. Infect Immun 1992;60:1279–1284.PubMedGoogle Scholar
  142. 142.
    Benfield TL, Vestbo J, Junge J, et al. Prognostic value of interleukin-8 in AIDS-associated Pneumocystis carinii pneumonia. Am J Respir Crit Care Med 1995;151:1058–1062.PubMedGoogle Scholar
  143. 143.
    Dutz W, Post C, Vessal K, et al. Endemic infantile Pneumocystic carinii infection: the Shiraz study. Natl Cancer Inst Monogr 1976;43:31–38.PubMedGoogle Scholar
  144. 144.
    Dutz W. Pneumocystis carinii infection and interstitial plasma cell pneumonia: what does history teach? Semin Diagn Pathol 1989;6:195–202.PubMedGoogle Scholar
  145. 145.
    Hughes WT. Pneumocystis carinii pneumonitis. Chest 1984;85:810–813.PubMedCrossRefGoogle Scholar
  146. 146.
    Burke BA, Good RA. Pneumocystis carinii infection. Medicine (Baltimore) 1973;52:23–51.PubMedCrossRefGoogle Scholar
  147. 147.
    Sepkowitz KA, Brown AE, Telzak EF, et al. Pneumocystis carinii pneumonia among patients without AIDS at a cancer hospital. JAMA 1992;267:832–837.PubMedCrossRefGoogle Scholar
  148. 148.
    Levine SJ, Masur H, Gil FJ, et al. Effect of aerosolized pentamidine prophylaxis on the diagnosis of Pneumocystis carinii pneumonia by induced sputum examination in patients infected with the human immunodeficiency virus. Am Rev Respir Dis 1991;144:760–764.PubMedCrossRefGoogle Scholar
  149. 149.
    Moe AA, Hardy WD. Pneumocystis carinii infection in the HIV-seropositive patient. Infect Dis Clin North Am 1994;8:331–364.PubMedGoogle Scholar
  150. 150.
    Hopewell PC. Pneumocystis carinii pneumonia: diagnosis. J Infect Dis 1988;6:1115–1119.CrossRefGoogle Scholar
  151. 151.
    Hoover DR, Saah AJ, Bacellar H, et al. Clinical manifestations of AIDS in the era of Pneumocystis prophylaxis. N Engl J Med 1993;329:1922–1226.PubMedCrossRefGoogle Scholar
  152. 152.
    Jacobson LP, Kirby AJ, Polk S, et al. Changes in survival after acquired immunodeficiency syndrome (AIDS): 1984–1991. Am J Epidemiol 1993;138:952–964.PubMedGoogle Scholar
  153. 153.
    Hughes WT. Natural mode of acquisition for de novo infection with Pneumocystis carinii. J Infect Dis 1982;145:842–848.PubMedCrossRefGoogle Scholar
  154. 154.
    Montaner JSG, Le T, Hogg R, et al. The changing spectrum of AIDS index diseases in Canada. AIDS 1994;8:693–696.PubMedCrossRefGoogle Scholar
  155. 155.
    Munoz A, Schrager LK, Bacellar H, et al. Trends in the incidence of outcomes defining acquired immunodeficiency syndrome (AIDS) in the multicenter AIDS cohort study: 1985–1991. Am J Epidemiol 1993;137:423–438.PubMedGoogle Scholar
  156. 156.
    Smith E, Orholm MK. Danish AIDS patients 1988–1993: a recent decline in Pneumocystis carinii pneumonia as AIDS-defining disease related to the period of known HIV positivity. Scand J Infect Dis 1994;26:517–522.PubMedCrossRefGoogle Scholar
  157. 157.
    Wall PG, Porter K, Noone A, et al. Changing incidence of Pneumocystis carinii pneumonia as initial AIDS defining disease in the United Kingdom. AIDS 1993;7:1523–1525.PubMedCrossRefGoogle Scholar
  158. 158.
    Jacobs JL, Libby DM, Winters RA, et al. A cluster of Pneumocystis carinii pneumonia in adults without predisposing illnesses. N Engl J Med 1991;324:246–250.PubMedCrossRefGoogle Scholar
  159. 159.
    Catterall JR, Potasman I, Remington JS. Pneumocystis carinii pneumonia in the patient with AIDS. Chest 1985;88:758–762.PubMedCrossRefGoogle Scholar
  160. 160.
    Engelberg LA, Lerner CW, Tapper ML. Clinical features of Pneumocystis pneumonia in the acquired immune deficiency syndrome. Am Rev Respir Dis 1984;130:689–694.PubMedGoogle Scholar
  161. 161.
    Gottlieb MS. Pulmonary disease in the acquired immune deficiency syndrome. Chest 1984;86:29S–31S.PubMedGoogle Scholar
  162. 162.
    Kales CP, Murren JR, Torres RA, et al. Early predictors of in-hospital mortality for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. Arch Intern Med 1987;147:1413–1417.PubMedCrossRefGoogle Scholar
  163. 163.
    Ognibene FP, Shelhamer J, Gill V, et al. The diagnosis of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome using subsegmental bronchoalveolar lavage. Am Rev Respir Dis 1984;129:929–32.PubMedGoogle Scholar
  164. 164.
    Sterling RP, Bradley BB, Khalil KG, et al. Comparison of biopsy-proven Pneumocystis carinii pneumonia in acquired immune deficiency syndrome patients and renal allograft recipients. Ann Thorac Surg 1984;38:494–499.PubMedCrossRefGoogle Scholar
  165. 165.
    Wollschlager CM, Khan FA, Chitkara RK, et al. Pulmonary manifestations of the acquired immunodeficiency syndrome (AIDS). Chest 1984;85:197–202.PubMedCrossRefGoogle Scholar
  166. 166.
    Limper AH, Offord KP, Smith TF, et al. Pneumocystis carinii pneumonia. Differences in lung parasite number and inflammation in patients with and without AIDS. Am Rev Respir Dis 1989;140:1204–1209.PubMedCrossRefGoogle Scholar
  167. 167.
    Gold JW. Clinical spectrum of infections in patients with HTLV-III-associated diseases. Cancer Res 1985;45:4652s–4654s.PubMedGoogle Scholar
  168. 168.
    Curtis J, Goodman P, Hopewell PC. Non-invasive tests in the diagnostic evaluation of Pneumocystis carinii pneumonia in patients with or suspected of having AIDS. Am Rev Respir Dis 1986;133:A182.Google Scholar
  169. 169.
    Pareja JG, Garland R, Koziel H. Use of adjunctive corticosteroids in severe adult non-HIV Pneumocystis carinii pneumonia. Chest 1998;113:1215–1224.PubMedCrossRefGoogle Scholar
  170. 170.
    Leoung GS, Feigal DW, Montgomery AB, et al. Aerosolized pentamidine for prophylaxis against Pneumocystis carinii pneumonia. The San Francisco community Prophylaxis Trial. N Engl J Med 1990;323:769–775.PubMedCrossRefGoogle Scholar
  171. 171.
    Dembinski AS, Smith DM, Goldsmith JC, Woods GL. Widespread dissemination of Pneumocystis carinii infection in a patient with acquired immunodeficiency syndrome receiving long-term treatment with aerosolized pentamidine. Am J Clin Pathol 1991;95:96–100.PubMedGoogle Scholar
  172. 172.
    Cote RJ, Rosenblum M, Telzak EE, et al. Disseminated Pneumocystis carinii infection causing extrapulmonary organ failure: clinical, pathologic, and immunohistochemical analysis. Mod Pathol 1990;3:25–31.PubMedGoogle Scholar
  173. 173.
    Ravinglione MC. Extrapulmonary pneumocystosis: the first 50 cases. Rev Infect Dis 1990;12:1127–1138.CrossRefGoogle Scholar
  174. 174.
    Telazak EE, Armstrong D. Extrapulmonary infection and other unusual manifestations of Pneumocystis carinii. In: Walzer PD, ed. Pneumocystis carinii pneumonia. 2nd ed. New York: Marcel Dekker, 1994:361.Google Scholar
  175. 175.
    Telzak EE, Cote RJ, Gold JW, et al. Extrapulmonary Pneumocystis carinii infections. Rev Infect Dis 1990;12:380–386.PubMedCrossRefGoogle Scholar
  176. 176.
    Davey RT, Margolis D, Kleiner D, et al. Digital necrosis and disseminated Pneumocystis carinii infection after aerosolized pentamidine prophylaxis. Ann Intern Med 1989;111:681–682.PubMedCrossRefGoogle Scholar
  177. 177.
    Feuerstein IM, Francis P, Raffeld M, et al. Widespread visceral calcifications in disseminated Pneumocystis carinii infection: CT characteristics. J Comput Assist Tomogr 1990;14:149–151.PubMedCrossRefGoogle Scholar
  178. 178.
    Lubat E, Megibow AJ, Balthazar EJ, et al. Extrapulmonary Pneumocystis carinii infections in AIDS: CT findings. Radiology 1990;174:157–160.PubMedGoogle Scholar
  179. 179.
    Lipschik GY, Gill VJ, Lundgren JD, et al. Improved diagnosis of Pneumocystis carinii infection in AIDS: CT findings. Radiology 1990;174:157–160.Google Scholar
  180. 180.
    Schluger N, Godwin T, Sepkowitz K, et al. Application of DNA amplification to Pneumocystosis: presence of serum Pneumocystic carinii DNA during human and experimentally induced Pneumocystis carinii pneumonia. J Exp Med 1992;176:1327–1327.PubMedCrossRefGoogle Scholar
  181. 181.
    Kuhlman JE, Kavuru M, Fishman EK, et al. Pneumocystis carinii pneumonia: spectrum of parenchymal CT findings. Radiology 1990;175:711–714.PubMedGoogle Scholar
  182. 182.
    Tarver RD, Teague SD, Heitkamp DE, et al. Radiology of community-acquired pneumonia. Radiol Clin North Am 2005;43:497–512.PubMedCrossRefGoogle Scholar
  183. 183.
    Cohen BA, Pomeranz S, Rabinowitz JG, et al. Pulmonary complications of AIDS: Radiologic features. AJR Am J Roentgenol 1984;143:115–122.PubMedCrossRefGoogle Scholar
  184. 184.
    Heron CW, Hine AL, Pozniak AL, et al. Radiographic features in patients with pulmonary manifestations of the acquired immune deficiency syndrome. Clin Radiol 195;36:583–588.CrossRefGoogle Scholar
  185. 185.
    Jules-Elysee KM, Stover DE, Zaman MB, et al. Aerosolized pentamidine: effect on diagnosis and presentation of Pneumocystis carinii pneumonia. Ann Intern Med 1990;112:750–757.PubMedCrossRefGoogle Scholar
  186. 186.
    Kennedy CA, Goetz MG Atypical roentgenographic manifestations of Pneumocystis carinii pneumonia. Arch Intern Med 1992;152:1390–1398.PubMedCrossRefGoogle Scholar
  187. 187.
    Barry SM, Lipman MC, Deery AR, et al. Immune recon-stitution pneumonitis following Pneumocystis carinii pneumonia in HIV-infected subjects. HIV Med 2002;3:207–211.PubMedCrossRefGoogle Scholar
  188. 188.
    Koval CE, Gigliotti F, Nevis D, et al. Immune reconstitu-tion syndrome after successful treatment of Pneumocystis carinii pneumonia in a man with human immunodeficiency virus type 1 infection. Clin Infect Dis 2002;35:491–493.PubMedCrossRefGoogle Scholar
  189. 189.
    Watts JC, Chandler FW. Evolving concepts of infection by Pneumocystis carinii. Pathol Annu 1991;26(pt 1):93–138.PubMedGoogle Scholar
  190. 190.
    Luna MA, Cleary KR. Spectrum of pathologic manifestations of Pneumocystis carinii pneumonia in patients with neoplastic diseases. Semin Diagn Pathol 1989;6:262–272.PubMedGoogle Scholar
  191. 191.
    Price RA, Hughes WT. Histopathology of Pneumocystis carinii infestation and infection in malignant disease in childhood. Hum Pathol 1974;5:737–752.PubMedCrossRefGoogle Scholar
  192. 192.
    Gal AA, Koss MN, Strigle S, Angritt P. Pneumocystis carinii infection in the acquired immunodeficiency syndrome. Semin Diagn Pathol 1989;6:287–299.PubMedGoogle Scholar
  193. 193.
    Watts JC, Chandler FW. Pneumocystis carinii pneumonitis: the nature and diagnostic significance of methenamine silver-positive “intracystic bodies”. Am J Surg Pathol 1985;9:744–751.PubMedCrossRefGoogle Scholar
  194. 194.
    Travis WD. Pathologic features. In: Walzer PD, ed. Pneumocystis carinii pneumonia. 2nd ed. New York: Marcel Dekker; 1994:155.Google Scholar
  195. 195.
    Travis WD, Pittaluga S, Lipschik GY, et al. Atypical pathologic manifestations of Pneumocystis carinii pneumonia in the acquired immune deficiency syndrome. Review of 123 lung biopsies from 76 patients with emphasis on cysts, vascular invasion, vasculitis, and granulomas. Am J Surg Pathol 1990;14:615–625.PubMedCrossRefGoogle Scholar
  196. 196.
    Saldana MJ, Mones JM. Pulmonary pathology in AIDS: atypical Pneumocystis carinii infection and lymphoid interstitial pneumonia. Thorax 1994;49:S46–55.PubMedCrossRefGoogle Scholar
  197. 197.
    Weber WR, Askin FB, Dehner LP. Lung biopsy in Pneumocystis carinii pneumonia: a histopathologic study of typical and atypical features. Am J Clin Pathol 1977;67:11–19.PubMedGoogle Scholar
  198. 198.
    Saldana MJ, Mones JM. Cavitation and other atypical manifestations of Pneumocystis carinii pneumonia. Semin Diagn Pathol 1989;6:273–286.PubMedGoogle Scholar
  199. 199.
    Askin FB, Katzenstein ALA. Pneumocystis infection masquerading as diffuse alveolar damage: a potential source of diagnostic error. Chest 1981;70:420–422.CrossRefGoogle Scholar
  200. 200.
    Nash G, Fligiel S. Pathologic features of the lung in the acquired immune deficiency syndrome (AIDS): an autopsy study of seventeen homosexual males. Am J Clin Pathol 1984;81:6–12.PubMedGoogle Scholar
  201. 201.
    Adegboyega PA, Adesokan A, Haque AK. A clinicopatho-logic study of adult respiratory distress syndrome in human immunodeficiency virus-infected patients. Am J Clin Pathol 1997;107(4):471.Google Scholar
  202. 202.
    Liu YC, Tomashefski JF Jr, Tomford JW, et al. Necrotizing Pneumocystis carinii vasculitis associated with lung necrosis and cavitation in a patient with acquired immunodeficiency syndrome. Arch Pathol Lab Med 1989;113:494–497.PubMedGoogle Scholar
  203. 203.
    Feuerstein IM, Archer A, Plada JM, et al. Thin-walled cavities, cysts and pneumothorax in Pneumocystis carinii pneumonia: further observations with histopathologic correlation. Radiology 1990;174:696–702.Google Scholar
  204. 204.
    Lee MM, Schinella RA. Pulmonary calcification caused by Pneumocystis carinii pneumonia. A clinicopathological study of 13 cases in acquired immune deficiency syndrome patients. Am J Surg Pathol 1991;15:376–380.PubMedCrossRefGoogle Scholar
  205. 205.
    Bleiweiss IJ, Jagirdar JS, Klein MJ, et al. Granulomatous Pneumocystis carinii pneumonia in three patients with the acquired immune deficiency syndrome. Chest 1988;94:580–583.PubMedCrossRefGoogle Scholar
  206. 206.
    Blumenfeld W, Basgoz N, Owen WF Jr, Schmidt DM. Granulomatous pulmonary lesions in patients with the acquired immunodeficiency syndrome (AIDS) and Pneumocystis carinii infection. Ann Intern Med 1988;109:505–507.PubMedCrossRefGoogle Scholar
  207. 207.
    Bondoc AY, White DA. Granulomatous Pneumocystis carinii pneumonia in patients with malignancy. Thorax 2002;57:435–437.PubMedCrossRefGoogle Scholar
  208. 208.
    Gal AA, Plummer AL, Langston AA, et al. Granulomatous Pneumocystis carinii pneumonia complicating hematopoietic cell transplantation. Pathol Res Pract 2002;198:553–558.PubMedCrossRefGoogle Scholar
  209. 209.
    Cupples JB, Blackie SP, Road JD. Granulomatous Pneumocystis carinii pneumonia mimicking tuberculosis. Arch Pathol Lab Med 1989;113:1281–1284.PubMedGoogle Scholar
  210. 210.
    Hartz JW, Geisinger KR, Scharyj M, Muss HB. Granulomatous pneumocystosis presenting as a solitary pulmonary nodule. Arch Pathol Lab Med 1985;109:466–469.PubMedGoogle Scholar
  211. 211.
    Halton SK, Krivisky B, Leonidas J. Pneumocystis carinii pneumonia presenting as a single pulmonary nodule. Pediatr Radiol 1986;16:59–60.PubMedCrossRefGoogle Scholar
  212. 212.
    Afessa B, Green WR, Williams WA, et al. Pneumocystis carinii pneumonia complicated by lymphadenopathy and pneumothorax. Arch Intern Med 1988;148:2651–2654.PubMedCrossRefGoogle Scholar
  213. 213.
    Saldana MJ, Mones JM, Martinez FR. The pathology of treated Pneumocystis carinii infection and lymphoid interstitial pneumonia. Thorax 1994;49:S46–55.PubMedCrossRefGoogle Scholar
  214. 214.
    El-Sadr W, Sidhu G. Persistence of trophozoites after successful treatment of Pneumocystis carinii pneumonia. Ann Intern Med 1986;105:889–890.PubMedCrossRefGoogle Scholar
  215. 215.
    Hardy WD, Northfelt DW, Drake TA. Fatal, disseminated pneumocystosis in a patient with acquired immunodeficiency syndrome receiving prophylactic aerosolized pentamidine. Am J Med 1989;87:329–331.PubMedCrossRefGoogle Scholar
  216. 216.
    Long EG, Smith JS, Meier J. Attachment of Pneumocystis carinii to rat pneumocytes. Lab Invest 1986;54:609–615.PubMedGoogle Scholar
  217. 217.
    Itatani CA, Marshall GJ. Ultrastructural morphology and staining characteristics of Pneumocystis carinii in situ and from bronchoalveolar lavage. J Parasitol 1988;74:700–712.PubMedCrossRefGoogle Scholar
  218. 218.
    Yoneda K, Walzer PD. Mechanism of pulmonary alveolar injury in experimental Pneumocystis carinii pneumonia in the rat. Br J Exp Pathol 1981;62:339–346.PubMedGoogle Scholar
  219. 219.
    Greaves TS, Strigle SM. The recognition of Pneumocystis carinii in Papanicolaou-stained smears. Acta Cytol 1985;29:714–720.PubMedGoogle Scholar
  220. 220.
    Bedrossian CWM, Mason MF, Gupta PK. Rapid cytologic diagnosis of Pneumocystis: a comparison of effective techniques. Semin Diagn Pathol 1989;6:245–261.PubMedGoogle Scholar
  221. 221.
    Ghall VS, Garcia RL, Skolom J. Fluorescence of Pneumocystis carinii in Papanicolaou smears. Hum Pathol 1984;15:907–909.CrossRefGoogle Scholar
  222. 222.
    Kim YK, Parulekar S, Yu P, et al. Evaluation of calcofluor white stain for detection of Pneumocystis carinii. Diagn Microbiol Infect Dis 1990;13:307–310.PubMedCrossRefGoogle Scholar
  223. 223.
    Watts JC, Chandler FW. Pneumocystosis. In: Connors DH, Chandler FW, et al., eds. Pathology of infectious diseases. Stamford, CT: Appleton & Lange; 1997:1241–1251.Google Scholar
  224. 224.
    Fraire AE, Kemp B, Greenberg SD, et al. Calcofluor white stain for the detection of Pneumocystis carinii in trans-bronchial lung biopsy specimens: a study of 68 cases. Mod Pathol 1996;9:861–864.PubMedGoogle Scholar
  225. 225.
    Baughman RP, Strohofer SS, Clinton BA, et al. The use of an indirect fluorescent antibody test for detecting Pneumocystis carinii. Arch Pathol Lab Med 1989;113:1062–1065.PubMedGoogle Scholar
  226. 226.
    Linder J, Radio SJ. Immunohistochemistry of Pneumocystis carinii. Semin Diagn Pathol 1989;6:238–244.PubMedGoogle Scholar
  227. 227.
    Midgley J, Parsons PA, Shanson DC, et al. Monoclonal immunofluorescence compared with silver stain for investigating Pneumocystis carinii pneumonia. J Clin Pathol 1991;44:75–76.PubMedCrossRefGoogle Scholar
  228. 228.
    Homer KS, Wiley WL, Smith AL, et al. Monoclonal antibody to Pneumocystis carinii: comparison with silver stain in bronchial lavage specimens. Am J Clin Pathol 1992;97:619–624.PubMedGoogle Scholar
  229. 229.
    Amin MB, Metzger E, Zarbo RJ. Detection of Pneumocystis carinii: comparative study of monoclonal antibody and silver staining. Am J Clin Pathol 1992;98:13–18.PubMedGoogle Scholar
  230. 230.
    Nayar R, Tabbara SO. Detecting Pneumocystis carinii by immunohistochemistry. Lab Med 1996;27:547–550.Google Scholar
  231. 231.
    Radio SJ, Hansen S, Goldsmith J, Linden J. Immunohistochemistry of Pneumocystis carinii infection. Mod Pathol 1990;3:462–469.PubMedGoogle Scholar
  232. 232.
    Gorelkin L, Chandler FW, Ewing EP. Staining qualities of cytomegalovirus inclusions in the lungs of patients with the acquired immunodeficiency syndrome. Hum Pathol 1986;17:926–929.PubMedCrossRefGoogle Scholar
  233. 233.
    Wakefield AE, Pixley FJ, Banerji S, et al. Detection of Pneumocystis carinii with DNA amplification. Lancet 1990;336:451–453.PubMedCrossRefGoogle Scholar
  234. 234.
    Wakefield AE, Guiver L, Miller RF, Hopkin JM. DNA amplification on induced sputum samples for diagnosis of Pneumocystis carinii pneumonia. Lancet 1991;337:1378–1379.PubMedCrossRefGoogle Scholar
  235. 235.
    Lipschik GY, Gill VJ, Lundgren JD, et al. Improved diagnosis of Pneumocystis carinii infection by polymerase chain reaction on induced sputum and blood. Lancet 1992;340:203–206.PubMedCrossRefGoogle Scholar
  236. 236.
    Saito K, Nakayamada S, Nakano K., et al. Detection of Pneumocystis carinii by DNA amplification in patients with connective tissue diseases: re-evaluation of clinical features of P. carinii pneumonia in rheumatic diseases. Rheumatology 2004;43:479–485.PubMedCrossRefGoogle Scholar
  237. 237.
    Brancart F, Rodriguez-Villalobos H, Fonteyne PA, et al. Quantitative TaqMan PCR for detection of Pneumocystis jiroveci. J Microbiol Methods 2005;61:381–387.PubMedCrossRefGoogle Scholar
  238. 238.
    Blumenfeld W, McCook O, Holodniy M, Katzenstein DA. Correlation of morphologic diagnosis of Pneumocystis carinii with the presence of Pneumocystis DNA amplified by the polymerase chain reaction. Mod Pathol 1992;5:103–106.PubMedGoogle Scholar
  239. 239.
    Pifer LL, Hughes WT, Murphy MX. Propagation of Pneumocystis carinii in vitro. Pediatr Res 1977;11:305–316.PubMedCrossRefGoogle Scholar
  240. 240.
    Cushion MT, Walzer PD. Growth and serial passage of Pneumocystis carinii in the A549 cell line. Infect Immun 1984;44:245–251.PubMedGoogle Scholar
  241. 241.
    Maddison SE, Walls KW, Haverkos HW, Juranek DD. Evaluation of serologic tests for Pneumocystis carinii antibody and antigenemia in patients with acquired immunodeficiency syndrome. Diagn Microbiol Infect Dis 1984;2:69–73.PubMedCrossRefGoogle Scholar
  242. 242.
    Walzer PD. Diagnosis of Pneumocystis carinii pneumonia. J Infect Dis 1988;157:629–632.PubMedCrossRefGoogle Scholar
  243. 243.
    Sattler FR, Cowan R, Nielsen DM, Ruskin J. Trimethoprim-sulfamethoxazole compared with pentamidine for treatment of Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. Ann Intern Med 1988;109:280–287.PubMedCrossRefGoogle Scholar
  244. 244.
    Kovacs JA, Masur H. Pneumocystis carinii pneumonia: therapy and prophylaxis. J Infect Dis 1988;158:254–259.PubMedCrossRefGoogle Scholar
  245. 245.
    Sattler FR, Feinberg J. New developments in the treatment of Pneumocystis carinii pneumonia. Chest 1992;101:451–457.PubMedCrossRefGoogle Scholar
  246. 246.
    NIH-UC Expert Panel. Consensus statement on the use of adjunctive therapy for Pneumocystis pneumonia in the acquired immunodeficiency syndrome. N Engl J Med 1990;323:1500–1504.CrossRefGoogle Scholar
  247. 247.
    CDC. Recommendations for prophylaxis against Pneumocystis carinii pneumonia for adults and adolescents infected with human immunodeficiency virus. MMWR 1992;41(no. RR-4):1–11.Google Scholar
  248. 248.
    DeRoux SJ, Adsay V, Ioachim HL. Disseminated pneumocystosis without pulmonary involvement during prophylactic aerosolized pentamidine therapy in a patient with the acquired immunodeficiency syndrome. Arch Pathol Lab Med 1991;115:1137–1140.PubMedGoogle Scholar
  249. 249.
    Falloon J, Kovacs J, Hughes W, et al. A preliminary evaluation of 566CB0 for the treatment of Pneumocystis pneumonia in patients with the acquired immunodeficiency syndrome. N Engl J Med 1991;325:1534–1538.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2008

Authors and Affiliations

  • Abida K. Haque
    • 1
  • Patrick A. Adegboyega
    • 2
  1. 1.Department of PathologySan Jacinto Methodist HospitalBaytownUSA
  2. 2.Department of PathologyUniversity of Texas Medical BranchGalvestonUSA

Personalised recommendations